BioCatalystWatch
VTRSWorkspace / VTRS / OverviewCompany library
Price
Market cap
Next catalystExpected 2026Selatogrel — SOS-AMI · Enrollment completionCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Creon High Dose

PreINDP1P2P3FilingApproved
Upcoming / outlook

Selatogrel

P2Y12 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Nefecon (VR-205)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Inpefa (sotagliflozin)

SGLT2 × SGLT1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Cenerimod

S1P1 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

Tyrvaya

Upcoming / outlook

MR-141 (phentolamine ophthalmic solution 0.75%)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Inpefa (sotagliflozin)

SGLT2 × SGLT1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Selatogrel

P2Y12 receptor

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Tyrvaya

Upcoming / outlook

Nefecon (VR-205)

PreINDP1P2P3FilingApproved
Upcoming / outlook

MR-141 (phentolamine ophthalmic solution 0.75%)

PreINDP1P2P3FilingApproved
Upcoming / outlook

Other pipelines

PreINDP1P2P3FilingApproved
GA Depot

PreINDP1P2P3FilingApproved
MR-146

Human nerve growth factor (hNGF)

Approved / commercial

Histamine H3 receptor

PreINDP1P2P3FilingApproved

α1-adrenergic receptor

Approved

PreINDP1P2P3FilingApproved

Histamine H3 receptor

PreINDP1P2P3FilingApproved
Inpefa (sotagliflozin)

SGLT2 × SGLT1

Approved

PreINDP1P2P3FilingApproved

α1-adrenergic receptor

PreINDP1P2P3FilingApproved

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Operating
Investing
Financing

Reported shares and borrowings

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

VTRS SEC archive